Avagene Therapeutics Inc.
Philadelphia, PA
- UEI
- U885YTE94268
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1701 Locust St UNIT 1906, Philadelphia, PA 19103, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Automated 2D cell & gene therapy manufacturing platform - project summary/ abstract adeno-associated virus (AAV) is… | National Institute of General Medical Sciences | $220,958 |
Quick answers
What is Avagene Therapeutics Inc.'s UEI?
Avagene Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is U885YTE94268.
Where is Avagene Therapeutics Inc. located?
Avagene Therapeutics Inc.'s physical address in SAM.gov is 1701 Locust St UNIT 1906, Philadelphia, PA 19103, USA.
Is Avagene Therapeutics Inc. registered in SAM.gov?
Yes. Avagene Therapeutics Inc.'s SAM.gov registration is active through July 13, 2027.
What is Avagene Therapeutics Inc.'s most recent federal award?
Avagene Therapeutics Inc.'s most recent federal grant award is Automated 2D cell & gene therapy manufacturing platform - project summary/ abstract adeno-associated virus (AAV) is… (R43GM165336), from National Institute of General Medical Sciences, on September 15, 2026.
On GovTribe
See Avagene Therapeutics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors